COVID-19: síndrome febril y clínica neurológica en neonato

Chacón-Aguilar, Rocío; Osorio-Cámara, Juana María; Sanjurjo-Jimenez, Isabel; González-González, Carolina; López-Carnero, Juan; Pérez-Moneo, Begoña

doi:10.1016/j.anpedi.2020.04.012

Cited by 24 publications

(6 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Regardless, severe disease in older pediatric populations has been cited, and therefore it is justified to closely follow the newborn age group as well [ 273 ]. Anecdotal reports of COVID-19 late-onset newborn infections between days 4 and 90 have been published, and the patients have fared well in resolution [ 29 , 245 , 250 , 256 , 259 , 265 , 266 , 274 – 278 ]. The need for intensive respiratory care in such late-onset infections is uncommon [ 259 , 265 ].…”

Section: Antenatal or Neonatal Infection With Sars-cov-2mentioning

confidence: 99%

“…The latter included considerable numbers of both community-acquired infections and nosocomial infections. Two reports provided evidence for a newborn febrile neurological presentation [ 262 , 274 ]. Whether asymptomatic or symptomatic, it is not known if a small proportion of newborns, whether with co-morbidities or not, will prove to be sources for prolonged or chronic shedding of the virus.…”

Section: Antenatal or Neonatal Infection With Sars-cov-2mentioning

confidence: 99%

See 1 more Smart Citation

A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19

Cimolai

2021

SN Compr. Clin. Med.

View full text Add to dashboard Cite

The maternal-fetal/newborn unit is established at risk for COVID-19 infection. This narrative review summarizes the contemporary and cumulative publications which detail maternal infection, antenatal and newborn infections, and maternal/fetal/newborn management and prevention. There is a wide spectrum of maternal disease, but the potential for severe disease albeit in a minority is confirmed. COVID-19 carries risk for preterm delivery. Pregnant females can suffer multisystem disease, and co-morbidities play a significant role in risk. Congenital infection has been supported by several anecdotal reports, but strong confirmatory data are few. No typical congenital dysmorphisms are evident. Nevertheless, placental vascular compromise must be considered a risk for the fetus during advanced maternal infections. Clinical manifestations of newborn infection have been mild to moderate and relatively uncommon. Proven antiviral therapy is of yet lacking. The mode of delivery is a medical decision that must include patient risk assessment and patient directives. Both presymptomatic and asymptomatic mothers and offspring can complicate infection control management with the potential for spread to others in several regards. In the interim, infections of the maternal-fetal-newborn unit must be taken seriously both for the disease so caused and the potential for further dissemination of disease.

show abstract

Section: Antenatal or Neonatal Infection With Sars-cov-2mentioning

confidence: 99%

Section: Antenatal or Neonatal Infection With Sars-cov-2mentioning

confidence: 99%

A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19

Cimolai

2021

SN Compr. Clin. Med.

View full text Add to dashboard Cite

show abstract

“…Xing et al, (30) 1 -6y Family transmission NS Yes/NS Yin et al, (31) 9y NS NS Yes/NS Chen et al, (32) 7m -17y Travel history and community transmission NS Yes/NS Morey-Olivé et al, (33) 2m e 6y Community transmission Cholestatic liver disease Yes/NS Liu et al, (34) 11m -9y Community transmission NS NS Chacón-Aguilar et al, (35) 26d NS NS Yes/06 Ji et al, (36) 9 e 15y Travel history No Yes/02…”

Section: Age Group Probable Contamination Of the Disease Pre-existing Disease/condition Hospitalization/ Length (Days)mentioning

confidence: 99%

Epidemiological profile of children and adolescents with COVID-19: a scoping review

et al. 2021

View full text Add to dashboard Cite

Objective: to map the epidemiological profile of children and adolescents with COVID-19 in the world literature. Methods: a scoping review systematized by the Joanna Briggs Institute protocol in the PubMed/MEDLINE, CINAHL, Web of Science, Scopus, Science direct and Google Scholar databases. Articles with children and/or adolescents with laboratory diagnosis of COVID-19 were used. Results: thirty-two articles were included in the review. Most children and adolescents were male, with contamination by family transmission. The most frequent clinical manifestations were fever, cough and diarrhea. Ten studies cited pre-existing condition/disease, and hospital length ranged from one to twenty days. Three deaths were reported and no study presented race/color, education and socioeconomic conditions. Conclusion: it was possible to screen the epidemiological profile with information about age group, sex, probable contamination of the disease, clinical manifestations, presence of pre-existing disease/condition, hospitalization and deaths among children and adolescents with COVID-19.

show abstract

“…La enfermedad por el nuevo coronavirus SARS-CoV-2 apareció en Wuhan, China, a finales del año 2019, y los primeros trabajos publicados con análisis pediátrico procedentes de dicho país describen cursos clínicos más leves que en adultos, fundamentalmente por sintomatología respiratoria 13 . Las razones descritas que apoyan esta idea se basan en que en pacientes pediátricos hay una alta población de linfocitos T vírgenes, los receptores de la enzima convertidora de angiotensina 2 (ACE2) son diferentes a los del adulto, y debido también a que estos, por lo regular, no cursan con comorbilidades 9,14 .…”

Section: Covid-19 Y Síndrome Inflamatorio Multisistémico (Sim-c)unclassified

Síndrome inflamatorio sistémico asociado a Covid-19 y la enfermedad de Kawasaki. Una revisión bibliográfica

Pozo

Rosado

2021

cysa

View full text Add to dashboard Cite

Introducción: la enfermedad de Kawasaki (EK) se define como una vasculitis multisistémica aguda y autolimitada asociada a lesiones coronarias. Los primeros casos se observaron en Japón a finales de 1960 y recibió dicho nombre debido al médico japonés que la describió por primera vez en el año 1967, Tomisaku Kawasaki. El síndrome inflamatorio multisistémico (SIM-C) se define como una patología que afecta generalmente a niños y adolescentes de 0 a 19 años, caracterizada por presencia de fiebre desde hace tres días o más y dos de los criterios diagnósticos establecidos. Objetivo: determinar y establecer las asociaciones clínicas entre el síndrome inflamatorio multisistémico asociado a Covid-19 y la enfermedad de Kawasaki. Metodología: estudio comparativo e informativo, en donde se analizaron 16 fuentes bibliográficas para establecer asociaciones entre el síndrome inflamatorio multisistémico vinculado a Covid-19 y la enfermedad de Kawasaki. Conclusión: la enfermedad de Kawasaki y el síndrome inflamatorio multisistémico poseen similitud en cuanto a manifestaciones clínicas se refiere, así como también, de acuerdo a las hipótesis, podrían estar explicadas por una infección viral como desencadenante de la enfermedad; ambas presentan afectación a nivel ocular, gastrointestinal y cardíaca.

show abstract

COVID-19: síndrome febril y clínica neurológica en neonato

Cited by 24 publications

References 4 publications

A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19

A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19

Epidemiological profile of children and adolescents with COVID-19: a scoping review

Síndrome inflamatorio sistémico asociado a Covid-19 y la enfermedad de Kawasaki. Una revisión bibliográfica

Contact Info

Product

Resources

About